Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,754,488
  • Shares Outstanding, K 43,828
  • Annual Sales, $ 3,183 M
  • Annual Income, $ 1,335 M
  • EBIT $ 1,493 M
  • EBITDA $ 1,578 M
  • 60-Month Beta 0.75
  • Price/Sales 7.85
  • Price/Cash Flow 17.29
  • Price/Book 3.46

Options Overview Details

View History
  • Implied Volatility 38.96% (+3.47%)
  • Historical Volatility 63.98%
  • IV Percentile 54%
  • IV Rank 19.17%
  • IV High 92.62% on 08/25/25
  • IV Low 26.23% on 06/18/25
  • Expected Move (DTE 11) 21.85 (3.93%)
  • Put/Call Vol Ratio 0.83
  • Today's Volume 484
  • Volume Avg (30-Day) 3,463
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 51,620
  • Open Int (30-Day) 43,706
  • Expected Range 534.52 to 578.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $6.70
  • Number of Estimates 7
  • High Estimate $7.10
  • Low Estimate $6.23
  • Prior Year $6.63
  • Growth Rate Est. (year over year) +1.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
495.50 +12.01%
on 03/09/26
607.89 -8.70%
on 03/30/26
+76.87 (+16.08%)
since 03/06/26
3-Month
455.63 +21.82%
on 01/20/26
607.89 -8.70%
on 03/30/26
+52.32 (+10.41%)
since 01/06/26
52-Week
266.98 +107.89%
on 04/09/25
607.89 -8.70%
on 03/30/26
+262.57 (+89.78%)
since 04/04/25

Most Recent Stories

More News
Stocks Pressured by Economic Fallout from Iran War

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.39%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.78%. June E-mini...

AMAT : 351.73 (+0.94%)
SNDK : 722.15 (+2.93%)
INTU : 416.93 (-1.31%)
$IUXX : 24,166.12 (+0.50%)
LITE : 773.37 (-6.47%)
UTHR : 555.73 (-1.61%)
ASML : 1,298.38 (-1.43%)
ZNM26 : 110-260 (+0.04%)
GLW : 145.67 (+2.31%)
ESM26 : 6,645.75 (+0.64%)
STX : 452.54 (+5.40%)
WDC : 304.39 (+3.19%)
Why United Therapeutics (UTHR) Stock Is Up Today

Why United Therapeutics (UTHR) Stock Is Up Today

UTHR : 555.73 (-1.61%)
Markets Turn Negative as Crude Oil Prices Surge

The S&P 500 Index ($SPX ) (SPY ) today is down -0.75%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.18%. Stock indexes turned lower...

AMAT : 351.73 (+0.94%)
AVGO : 313.98 (-0.18%)
INTU : 416.93 (-1.31%)
DDOG : 116.60 (-3.12%)
EXPE : 228.79 (+1.55%)
$IUXX : 24,166.12 (+0.50%)
UTHR : 555.73 (-1.61%)
ASML : 1,298.38 (-1.43%)
ZNM26 : 110-260 (+0.04%)
CLK26 : 112.78 (+1.11%)
STX : 452.54 (+5.40%)
WDC : 304.39 (+3.19%)
Stocks Rebound as T-note Yields Tumble

The S&P 500 Index ($SPX ) (SPY ) today is up +0.42%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. June E-mini S&P futures (ESM26...

MSTR : 127.42 (+6.33%)
INTU : 416.93 (-1.31%)
DDOG : 116.60 (-3.12%)
GLXY : 18.11 (+2.66%)
EXPE : 228.79 (+1.55%)
$IUXX : 24,166.12 (+0.50%)
COIN : 175.23 (+2.20%)
UTHR : 555.73 (-1.61%)
ZNM26 : 110-260 (+0.04%)
ESM26 : 6,645.75 (+0.64%)
$DOWI : 46,618.66 (+0.25%)
^BTCUSD : 69,725.72 (+4.30%)
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2

Nebulized Tyvaso ® (treprostinil) Inhalation Solution demonstrated superiority over placebo for the change in absolute forced vital capacity by 130.1 mL and reduced the risk of clinical...

UTHR : 555.73 (-1.61%)
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm

1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm

TLYS : 4.39 (+4.52%)
UTHR : 555.73 (-1.61%)
BMY : 59.26 (-0.57%)
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers

Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers

UTHR : 555.73 (-1.61%)
2 Mid-Cap Stocks for Long-Term Investors and 1 We Avoid

2 Mid-Cap Stocks for Long-Term Investors and 1 We Avoid

TTD : 22.33 (+1.27%)
BLDR : 81.98 (+3.61%)
UTHR : 555.73 (-1.61%)
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

RGR : 40.65 (-0.88%)
ZG : 41.72 (+2.66%)
UTHR : 555.73 (-1.61%)
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program

Agreements for aggregate $1.5 billion Accelerated Share Repurchase ( ASR ) already executed, with an additional $500 million authorized within the next year

UTHR : 555.73 (-1.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 604.57
2nd Resistance Point 591.22
1st Resistance Point 578.01
Last Price 555.73
1st Support Level 551.45
2nd Support Level 538.10
3rd Support Level 524.89

See More

52-Week High 607.89
Last Price 555.73
Fibonacci 61.8% 477.66
Fibonacci 50% 437.43
Fibonacci 38.2% 397.21
52-Week Low 266.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.